Item 5. Market for Registrant’s Common Equity
Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
On August 31, 2021, the Company commenced the
trading of its common stock on the Nasdaq Capital Market under the symbol “FCUV.” On January 28, 2022, the Company commenced
trading of its common stock on the Nasdaq Global Market under the symbol “FCUV.” On April 1, 2024, the last reported sale
price of our common stock as reported on the Nasdaq Global Market was $0.40 per share.
On September 23, 2014, our common stock was verified
for trading on the OTCQB Market under the trading symbol “FCUV.” Prior to that time, there was no public market for our stock.
The following table sets forth for the indicated periods the high and low intra-day sales price per share for our common stock on the
Nasdaq Capital Market (as applicable) for the four quarters of 2022 and 2023. As of April 1, 2024, our common stock trades upon the Nasdaq
Global Market.
High
Low
2022: First Quarter
$ 9.45
$ 4.12
2022: Second Quarter
$ 9.72
$ 6.67
2022: Third Quarter
$ 10.95
$ 6.25
2022: Fourth Quarter
$ 8.99
$ 3.93
2023: First Quarter
$ 4.71
$ 2.37
2023: Second Quarter
$ 2.46
$ 1.45
2023: Third Quarter
$ 1.97
$ 1.5
2023: Fourth Quarter
$ 2.17
$ 1.37
Holders.
As of April 1, 2024, there were 361 record
holders of 64,771,817 shares of the Company’s common stock. The number of record holders was determined from the records of
our transfer agent and does not include beneficial owners of common stock whose shares are held in the names of various security
brokers, dealers, and registered clearing agencies. The transfer agent of our common stock is VStock Transfer, LLC.
Dividends.
The Company has not paid any cash dividends to
date and does not anticipate or contemplate paying dividends in the foreseeable future. It is the present intention of management to utilize
all available funds for the development of the Company’s business. However, we cannot provide any assurance that we will or will
not declare or pay cash dividends on our common stock. Any future determination to declare cash dividends will be made at the discretion
of our Board of Directors, subject to applicable laws, and will depend on our financial condition, results of operations, capital requirements,
general business conditions and other factors that our Board of Directors may deem relevant.
43
Securities Authorized for Issuance Under Equity Compensation Plans
On December 15, 2018, our Board of Directors presented
the 2018 Equity Incentive Plan to the shareholders. On December 17, 2018, the holders of 63.051% of our issued and outstanding shares
of common stock adopted a resolution by written consent without a meeting adopting the 2018 Equity Incentive Plan. The plan reserves an
aggregate of 1,000,000 shares of the Company’s common stock, which provides for the payment of various forms of incentive compensation
to employees, consultants, executives, and directors of the Company. The 2018 Equity Incentive Plan provides for the grant of the following
types of stock awards: (i) incentive stock options; (ii) non-statutory stock options; (iii) stock appreciation rights; (iv) restricted
stock awards; (v) restricted stock unit awards; and (vi) other stock awards. Under the 2018 Equity Incentive Plan, a ten percent stockholder
will not be granted an incentive stock option unless the exercise price of such option is at least one hundred and ten percent of the
fair market value on the date of grant and the option is not exercisable after the expiration of five years from the grant date. The Board
of Directors determines the vesting schedule of the grants with broad discretion. On August 6, 2019, each member of the Board was granted
45,000 options to purchase shares at $3.80 per share. On December 11, 2020, each member of the Board was granted 22,500 options to purchase
shares at $2.00 per share. On December 31, 2021, each member of the Board was granted 22,500 options to purchase shares at $5.91 per share.
On December 30, 2022, each member of the Board was granted 22,500 options to purchase shares at $4.27 per share.
Recent sales of unregistered securities.
None.
Issuer Purchases of Equity Securities
We did not repurchase any of our equity securities
during the years ended December 31, 2021, 2020, 2019, 2018, 2017, the nine months ended December 31, 2016, the year ended March 31, 2016,
2015, 2014 or the period from December 4, 2012 (inception) to March 31, 2013.
Item 6. [RESERVED]